Asia Pacific Lung Cancer Surgery Market Research Report – Segmented By Procedure, Device, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis From 2026 to 2034

ID: 1898
Pages: 133

Asia Pacific Lung Cancer Surgery Market Size

The Asia Pacific Lung Cancer Surgery Market size was valued at USD 7.85 billion in 2025 and is anticipated to reach USD 8.56 billion in 2026 from USD 17.06 billion by 2034, growing at a CAGR of 9% during the forecast period from 2026 to 2034.

Lung Cancer is a kind of cancer that starts in Lung tissue or its surrounding parts. There are various types of treatments available to treat cancer like Chemotherapy, such as chemotherapy, Laser Therapy, and Surgery. Surgery involves the removal of an infected parts from the lungs. In some cases, surgery will be used with other treatment methods to cure cancer. Surgery is only used if cancer cells don’t spread very near to the heart.

Rising pollution levels, an increasing number of cigarette smokers, rising incidence and prevalence of Lung Cancer and rising geriatric population are some of the major factors driving the market.

However, the high cost of Lung Cancer surgery is restraining the growth of the market.

On the basis of procedure, Minimally Invasive surgeries are expected to grow at the highest CAGR owing to the rising awareness among people of the importance of early detection of lung cancer and the advantages of Minimally Invasive Surgeries over conventional surgeries.

On the basis of the device, the Surgical Instruments segment is expected to dominate the market owing to the shorter lifespan of devices and wider adoption of these devices.

Geographically, Europe has the second-largest market after North America owing to its Advanced Healthcare facilities and higher awareness among people and greater economic stability.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2025 to 2034

Base Year

2025

Forecast Period

2026 to 2034

CAGR

9%.

Segments Covered

By Procedure, Device and Region

Various Analyses Covered

Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Countries Covered

India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, the Philippines, Indonesia, Singapore, and the Rest of APAC.

Market Leaders Profiled

Ethicon US LLC, Intuitive Surgical Inc., AngioDynamics Inc., Olympus Corporation, Accuray Inc., Ackermann Instrumente GmbH, Teleflex Inc., KARL STORZ GmbH, Scanlan International Inc., and Trokamed GmbH.

KEY MARKET PLAYERS

Notable companies dominating the Asia Pacific Lung Cancer Surgery Market include

  • Ethicon US LLC
  • Intuitive Surgical Inc.
  • AngioDynamics Inc.
  • Olympus Corporation
  • Accuray Inc.
  • Ackermann Instrumente GmbH
  • Teleflex Inc.
  • KARL STORZ GmbH
  • Scanlan International Inc.
  • Trokamed GmbH

MARKET SEGMENTATION

This research report on the Asia Pacific Lung Cancer Surgery Market has been segmented & sub-segmented into the following categories

By Procedure

  • Thoracotomy
    • Lobectomy
    • Pneumonectomy
    • Sleeve Resection
    • Segmentectomy
  • Minimally Invasive

By Device

  • Surgical
    • Clamps
    • Forceps
    • Retractors
    • Staplers
    • Cutters
    • Scissors
    • Elevators
    • RIB Sheers
    • Trocars
  • Monitoring
    • Cameras
    • Video Support
  • Visualizing Systems
    • Endoscopic Trocars with optical views
    • Endo surgical Equipment

By Country

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

Related Reports

Click for Request Sample